| Gaia data release 2-summary of the contents and survey properties AGA Brown, A Vallenari, T Prusti, JHJ De Bruijne, C Babusiaux, ... Astronomy & astrophysics 616, A1, 2018 | 8014 | 2018 |
| Analysis of shared heritability in common disorders of the brain Brainstorm Consortium, V Anttila, B Bulik-Sullivan, HK Finucane, ... Science 360 (6395), eaap8757, 2018 | 1365 | 2018 |
| Genome-wide association study identifies 30 loci associated with bipolar disorder EA Stahl, G Breen, AJ Forstner, A McQuillin, S Ripke, V Trubetskoy, ... Nature genetics 51 (5), 793-803, 2019 | 1352 | 2019 |
| European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD SJJ Kooij, S Bejerot, A Blackwell, H Caci, M Casas-Brugué, PJ Carpentier, ... BMC psychiatry 10, 1-24, 2010 | 1208 | 2010 |
| Genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders PH Lee, V Anttila, H Won, YCA Feng, J Rosenthal, Z Zhu, EM Tucker-Drob, ... Cell 179 (7), 1469-1482. e11, 2019 | 1026 | 2019 |
| Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs B Devlin, JR Kelsoe, P Sklar, MJ Daly, MC O'Donovan, N Craddock, ... Nature genetics 45 (9), 984-994, 2013 | 753 | 2013 |
| Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology N Mullins, AJ Forstner, KS O’Connell, B Coombes, JRI Coleman, Z Qiao, ... Nature genetics 53 (6), 817-829, 2021 | 716 | 2021 |
| Updated European Consensus Statement on diagnosis and treatment of adult ADHD JJS Kooij, D Bijlenga, L Salerno, R Jaeschke, I Bitter, J Balazs, J Thome, ... European psychiatry 56 (1), 14-34, 2019 | 566 | 2019 |
| Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways B Devlin, JR Kelsoe, P Sklar, MJ Daly, MC O'Donovan, N Craddock, ... Nature neuroscience 18 (2), 199-209, 2015 | 521 | 2015 |
| Genomic dissection of bipolar disorder and schizophrenia, including 28 subphenotypes DM Ruderfer, S Ripke, A McQuillin, J Boocock, EA Stahl, JMW Pavlides, ... Cell 173 (7), 1705-1715. e16, 2018 | 503 | 2018 |
| COVID‐19 and implications for eating disorders F Fernández‐Aranda, M Casas, L Claes, DC Bryan, A Favaro, R Granero, ... European Eating Disorders Review 28 (3), 239, 2020 | 502 | 2020 |
| A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication M Arcos-Burgos, M Jain, MT Acosta, S Shively, H Stanescu, D Wallis, ... Molecular psychiatry 15 (11), 1053-1066, 2010 | 333 | 2010 |
| The impact of the COVID-19 pandemic on the mental health of healthcare professionals MD Braquehais, S Vargas-Cáceres, E Gómez-Durán, G Nieva, S Valero, ... QJM: An International Journal of Medicine 113 (9), 613-617, 2020 | 286 | 2020 |
| Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults X Castells, L Blanco‐Silvente, R Cunill Cochrane Database of Systematic Reviews, 2018 | 263 | 2018 |
| Efficacy of methylphenidate for adults with attention-deficit hyperactivity disorder: a meta-regression analysis X Castells, JA Ramos-Quiroga, D Rigau, R Bosch, M Nogueira, X Vidal, ... CNS drugs 25, 157-169, 2011 | 235 | 2011 |
| A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder R Medori, JA Ramos-Quiroga, M Casas, JJS Kooij, A Niemelä, GE Trott, ... Biological psychiatry 63 (10), 981-989, 2008 | 235 | 2008 |
| Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: results from an international multi-center study exploring DSM-IV and DSM-5 … G van de Glind, M Konstenius, MWJ Koeter, ... Drug and alcohol dependence 134, 158-166, 2014 | 234 | 2014 |
| Multicenter analysis of the SLC6A3/DAT1 VNTR haplotype in persistent ADHD suggests differential involvement of the gene in childhood and persistent ADHD B Franke, AA Vasquez, S Johansson, M Hoogman, J Romanos, ... Neuropsychopharmacology 35 (3), 656-664, 2010 | 231 | 2010 |
| Joint analysis of psychiatric disorders increases accuracy of risk prediction for schizophrenia, bipolar disorder, and major depressive disorder R Maier, G Moser, GB Chen, S Ripke, D Absher, I Agartz, H Akil, F Amin, ... The American Journal of Human Genetics 96 (2), 283-294, 2015 | 221 | 2015 |
| Psychiatric comorbidity in treatment‐seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study K van Emmerik‐van Oortmerssen, G van de Glind, MWJ Koeter, S Allsop, ... Addiction 109 (2), 262-272, 2014 | 207 | 2014 |
